PTC Therapeutics is an established rare disease company focused on neurological, neuromuscular, metabolic, and genetically defined disorders. The company has developed therapies for rare diseases such as Duchenne muscular dystrophy and aromatic L-amino acid decarboxylase deficiency, among other programs.
Read More
PSI CRO is a privately held full-service CRO with a strong reputation in clinical trial execution, particularly for sponsors seeking operational focus, therapeutic expertise, and global study management. The company supports Phase II–III and related clinical development programs across multiple therapeutic areas.
Read More
ProPharma is an established healthcare institution whose principal relevance to this ranking lies in clinical research, regulatory, pharmacovigilance and medical information. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in contract Research Organizations.
Read More
Premier Research is an established healthcare institution whose principal relevance to this ranking lies in biotech-focused clinical development and rare-disease expertise. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in contract Research Organizations.
Read More
Diagnostic Imaging Associates is an established healthcare institution whose principal relevance to this ranking lies in physician-led regional radiology and imaging services. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in diagnostic Imaging Providers.
Read More
Diagnexia is an established healthcare institution whose principal relevance to this ranking lies in digital pathology reporting and specialist diagnostic networks. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in pathology & Laboratory Networks.
Read More
DeepHealth is RadNet’s wholly owned AI-powered health informatics business, with products for radiology workflow and clinical AI. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in aI-Enabled Diagnostics Providers.
Read More
Dasa Diagnósticos is an established healthcare institution whose principal relevance to this ranking lies in pathology & laboratory networks. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in pathology & Laboratory Networks.
Read More
Cue Health Inc. filed for Chapter 7 bankruptcy on 28 May 2024. Its SEC filing states that a trustee would administer its bankruptcy estate and liquidate its assets. The linked ranking concerns mobile & at-home diagnostics providers and should be read in the context of that wind-down.
Read More
Craft Body Scan is an established healthcare institution whose principal relevance to this ranking lies in preventive health screening providers. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in preventive Health Screening Providers.
Read More
CPL — Clinical Pathology Laboratories is an established healthcare institution whose principal relevance to this ranking lies in large regional clinical and anatomic laboratory network. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in pathology & Laboratory Networks.
Read More
Congenica provides clinical genomic interpretation software and services for rare disease and oncology. It is now part of SeqOne, following the acquisition announced in September 2025. Highest 2026 tier: Tier III Genetic Testing & Genomics Providers 1 ranking category Overview
Read More
Color Health is a population health and genomics provider focused on making genetic testing more accessible and actionable across broader patient populations. The company began with hereditary cancer risk testing and has since expanded into population health implementation, clinical programs, and preventive care infrastructure.
Read More
Cobalt Health is an established healthcare institution whose principal relevance to this ranking lies in diagnostic imaging providers. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in diagnostic Imaging Providers.
Read More
Cleerly is an established healthcare institution whose principal relevance to this ranking lies in AI coronary imaging and cardiovascular risk assessment. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in aI-Enabled Diagnostics Providers.
Read More
Cerba Research is a major clinical trial laboratory services provider connected to Cerba HealthCare’s broader diagnostics platform. The organization supports clinical development programs through central laboratory services, specialty testing, biomarker development, genomics, flow cytometry, pathology, and clinical trial sample management.
Read More
Cerba HealthCare is a major European laboratory medicine group with a strong presence in routine clinical pathology, specialty diagnostics, anatomic pathology, and clinical trial laboratory services. The company reports 1,200 clinical pathologists and 1,360 laboratories across France, Luxembourg, Belgium, Italy, and Africa, supported by broader specialty entities including Cerba Research and Cerba Path.
Read More
Ceras Health is an established healthcare institution whose principal relevance to this ranking lies in mobile & at-home diagnostics providers. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in mobile & At-Home Diagnostics Providers.
Read More
Centogene is an established healthcare institution whose principal relevance to this ranking lies in genetic testing & genomics providers. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in genetic Testing & Genomics Providers.
Read More
Castle Biosciences is an established healthcare institution whose principal relevance to this ranking lies in molecular diagnostics for dermatologic and other cancers. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in precision Medicine Diagnostics Providers.
Read More